{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Sanofi", "item": "https://www.patentleaderboard.com/2021/company/sanofi"}, {"@type": "ListItem", "position": 4, "name": "Andreas Evers", "item": "https://www.patentleaderboard.com/2021/inventor/fl:an_ln:evers-6"}]}

Home › 2021 › Sanofi › Andreas Evers

AE

Andreas Evers — 2 Patents in 2021

SASanofi: 1 patents #52 of 191Top 30%

Frankfurt am Main, DE: #43 of 220 inventorsTop 20%

Overall (2021): #181,247 of 548,734Top 35%

2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11141489	Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid	Dieter Kadereit, Michael Wagner, Thomas Olpp, Nino Meyer, Martin Bossart +5 more	2021-10-12	$18,446,000
11046743	Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes	Torsten Haack, Oliver Plettenburg, Michael Wagner, Martin Bossart, Romain BERTRAND	2021-06-29

Andreas Evers — 2 Patents in 2021

Issued Patents 2021

Patent Widget